This podcast series reveals the understated, but long-standing, and challenging problem of the lack of an effective technology for counting therapeutic tissue stem cells. It explores a secret that has been so well kept for so long by the stem cell research and stem cell medicine disciplines that many experts fail to even understand or acknowledge that the problem exists any more. In the podcast, with moderator Jordan Rich leading the expository discussion, Dr. James L. Sherley, M.D., Ph.D., Director and Founder of biotechnology tools company Asymmetrex, discloses the nature of the stem cell counting problem and its widespread detrimental effects in limiting progress in stem cell research, stem cell medicine, drug development, and environmental health sciences. Dr. Sherley also describes the recent development of a solution to the counting problem. Together, he and Jordan Rich consider both the immediate impact of the new stem cell counting technology and its future vision for advancing a near era of medicine.
All content for Counting Stem Cells is the property of Dr. James L. Sherley and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
This podcast series reveals the understated, but long-standing, and challenging problem of the lack of an effective technology for counting therapeutic tissue stem cells. It explores a secret that has been so well kept for so long by the stem cell research and stem cell medicine disciplines that many experts fail to even understand or acknowledge that the problem exists any more. In the podcast, with moderator Jordan Rich leading the expository discussion, Dr. James L. Sherley, M.D., Ph.D., Director and Founder of biotechnology tools company Asymmetrex, discloses the nature of the stem cell counting problem and its widespread detrimental effects in limiting progress in stem cell research, stem cell medicine, drug development, and environmental health sciences. Dr. Sherley also describes the recent development of a solution to the counting problem. Together, he and Jordan Rich consider both the immediate impact of the new stem cell counting technology and its future vision for advancing a near era of medicine.
In this first episode, Dr. James Sherley talks with Jordan Rich about how stem cells are used for medicine, and they consider the tension between FDA-authorized clinical trials and treatments in private stem cell clinics. Their discussion discloses a bigger problem that compromises all stem cell treatments, even approved ones.
Counting Stem Cells
This podcast series reveals the understated, but long-standing, and challenging problem of the lack of an effective technology for counting therapeutic tissue stem cells. It explores a secret that has been so well kept for so long by the stem cell research and stem cell medicine disciplines that many experts fail to even understand or acknowledge that the problem exists any more. In the podcast, with moderator Jordan Rich leading the expository discussion, Dr. James L. Sherley, M.D., Ph.D., Director and Founder of biotechnology tools company Asymmetrex, discloses the nature of the stem cell counting problem and its widespread detrimental effects in limiting progress in stem cell research, stem cell medicine, drug development, and environmental health sciences. Dr. Sherley also describes the recent development of a solution to the counting problem. Together, he and Jordan Rich consider both the immediate impact of the new stem cell counting technology and its future vision for advancing a near era of medicine.
